Dosimetric Implications of Computerised Tomography-Only versus Magnetic Resonance-Fusion Contouring in Stereotactic Body Radiotherapy for Prostate Cancer.

about

Dosimetric Implications of Computerised Tomography-Only versus Magnetic Resonance-Fusion Contouring in Stereotactic Body Radiotherapy for Prostate Cancer.

Item

http://www.wikidata.org/entity/Q55425041

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Dosimetric Implications of Com ...... iotherapy for Prostate Cancer.

@en

Dosimetric Implications of Com ...... iotherapy for Prostate Cancer.

@nl

type

Item

label

Dosimetric Implications of Com ...... iotherapy for Prostate Cancer.

@en

Dosimetric Implications of Com ...... iotherapy for Prostate Cancer.

@nl

prefLabel

Dosimetric Implications of Com ...... iotherapy for Prostate Cancer.

@en

Dosimetric Implications of Com ...... iotherapy for Prostate Cancer.

@nl

P1476

Dosimetric Implications of Com ...... iotherapy for Prostate Cancer.

@en

P2093

Alison C Tree

http://www.w3.org/2001/XMLSchema#string

Daniel R Henderson

http://www.w3.org/2001/XMLSchema#string

Kevin J Harrington

http://www.w3.org/2001/XMLSchema#string

Nicholas J van As

http://www.w3.org/2001/XMLSchema#string

P2860

Stereotactic body radiation therapy: the report of AAPM Task Group 101.

A comparison of the incidence and location of positive surgical margins in robotic assisted laparoscopic radical prostatectomy and open retropubic radical prostatectomy.

A single-center study of 100 consecutive patients with localized prostate cancer treated with stereotactic body radiotherapy.

Phase I dose-escalation study of stereotactic body radiation therapy for low- and intermediate-risk prostate cancer

Randomized Phase III Noninferiority Study Comparing Two Radiotherapy Fractionation Schedules in Patients With Low-Risk Prostate Cancer.

Stereotactic body radiation therapy (SBRT) for clinically localized prostate cancer: the Georgetown University experience.

Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: 5-year outcomes of the randomised, non-inferiority, phase 3 CHHiP trial

The CyberKnife Robotic Radiosurgery System in 2010.

Stereotactic body radiotherapy for prostate cancer.

Can images obtained with high field strength magnetic resonance imaging reduce contouring variability of the prostate?

P31

scholarly article

P356

10.3390/MEDICINES5020032

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-04-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29621134

http://www.w3.org/2001/XMLSchema#string

P921

radiation therapy

P932

6023312

http://www.w3.org/2001/XMLSchema#string